$OFIX
Orthofix Medical Inc. Stock $ofix

$ofix Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000156459021041921 Filed on August 06, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$121.4M	$73.14M
YoY Change	65.99%	-36.87%
Cost Of Revenue	$27.44M	$23.20M
YoY Change	18.27%	-10.12%
Gross Profit	$93.96M	$50.00M
YoY Change	87.91%	-44.47%
Gross Profit Margin	77.4%	68.37%
Selling, General & Admin	$75.67M	$58.50M
YoY Change	29.36%	-25.76%
% of Gross Profit	80.54%	117.0%
Research & Development	$13.12M	$8.800M
YoY Change	49.1%	-2.22%
% of Gross Profit	13.97%	17.6%
Depreciation & Amortization	$7.602M	$7.000M
YoY Change	8.6%	12.9%
% of Gross Profit	8.09%	14.0%
Operating Expenses	$88.79M	$70.90M
YoY Change	25.24%	-20.86%
Operating Profit	$4.267M	-$20.90M
YoY Change	-120.42%	-4734.15%
Interest Expense	-$550.0K	-$900.0K
YoY Change	-38.89%	-280.0%
% of Operating Profit	-12.89%
Other Income/Expense, Net	$951.0K	$5.100M
YoY Change	-81.35%	-2650.0%
Pretax Income	$4.668M	-$16.83M
YoY Change	-127.73%	-2604.76%
Income Tax	$2.248M	$1.600M
% Of Pretax Income	48.16%
Net Earnings	$2.420M	-$18.42M
YoY Change	-113.14%	3268.19%
Net Earnings / Revenue	1.99%	-25.19%
Basic Earnings Per Share	$0.12
Diluted Earnings Per Share	$0.12	-$958.3K
COMMON SHARES
Basic Shares Outstanding	19.65K	19.22M
Diluted Shares Outstanding	19.94K	19.22M

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.97M	$172.9M
YoY Change	-53.75%	231.86%
Cash & Equivalents	$79.97M	$172.9M
Short-Term Investments
Other Short-Term Assets	$23.48M	$21.20M
YoY Change	10.75%	0.95%
Inventory	$81.55M	$82.05M
Prepaid Expenses
Receivables	$73.45M	$67.40M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$258.5M	$343.6M
YoY Change	-24.78%	47.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$66.42M	$70.30M
YoY Change	-5.51%	9.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$36.10M	$38.70M
YoY Change	-6.72%	42.26%
Total Long-Term Assets	$243.6M	$252.1M
YoY Change	-3.39%	-1.51%
TOTAL ASSETS
Total Short-Term Assets	$258.5M	$343.6M
Total Long-Term Assets	$243.6M	$252.1M
Total Assets	$502.0M	$595.7M
YoY Change	-15.73%	21.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.10M	$14.90M
YoY Change	34.87%	-23.68%
Accrued Expenses	$2.107M	$1.900M
YoY Change	10.89%	5.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.551M	$400.0K
YoY Change	537.75%	33.33%
Total Short-Term Liabilities	$81.65M	$89.60M
YoY Change	-8.88%	31.79%
LONG-TERM LIABILITIES
Long-Term Debt	$20.19M	$100.0M
YoY Change	-79.81%	380.77%
Other Long-Term Liabilities	$37.89M	$38.60M
YoY Change	-1.85%	-26.03%
Total Long-Term Liabilities	$58.08M	$100.0M
YoY Change	-41.92%	91.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$81.65M	$89.60M
Total Long-Term Liabilities	$58.08M	$100.0M
Total Liabilities	$139.7M	$250.7M
YoY Change	-44.27%	77.79%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$362.3M	$345.0M
YoY Change
Total Liabilities & Shareholders Equity	$502.0M	$595.7M
YoY Change	-15.73%	21.87%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	$2.420M	-$18.42M
YoY Change	-113.14%	3268.19%
Depreciation, Depletion And Amortization	$7.602M	$7.000M
YoY Change	8.6%	12.9%
Cash From Operating Activities	-$2.136M	$17.60M
YoY Change	-112.14%	89.25%
INVESTING ACTIVITIES
Capital Expenditures	-$4.992M	-$4.400M
YoY Change	13.45%	-18.52%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$4.992M	-$4.400M
YoY Change	13.45%	-18.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.628M	101.6M
YoY Change	-107.51%	-8566.67%
NET CHANGE
Cash From Operating Activities	-2.136M	17.60M
Cash From Investing Activities	-4.992M	-4.400M
Cash From Financing Activities	-7.628M	101.6M
Net Change In Cash	-14.76M	114.8M
YoY Change	-112.85%	4151.85%
FREE CASH FLOW
Cash From Operating Activities	-$2.136M	$17.60M
Capital Expenditures	-$4.992M	-$4.400M
Free Cash Flow	$2.856M	$22.00M
YoY Change	-87.02%	49.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:OtherAssetsNoncurrent
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentNet
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentNet
CY2021Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1184000
CY2022Q3	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	6 months
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1711000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3859000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	812000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	355369000
	us-gaap	Net Income Loss NetIncomeLoss	-3396000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15002000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13269000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	1779000
	ofix	Amortization Of Lease Assets Debt Costs And Other Assets AmortizationOfLeaseAssetsDebtCostsAndOtherAssets	1908000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-214000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1564000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3936000
	us-gaap	Share Based Compensation ShareBasedCompensation	8558000
	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	198000
	ofix	Interest And Gain Loss On Investment Securities InterestAndGainLossOnInvestmentSecurities	-219000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-75000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6900000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	986000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2655000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-468000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	6507000
	ofix	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-43000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2662000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4782000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-6905000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1022000
	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	-2880000
	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13851000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	18000000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	8405000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-687000
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	172888000
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	554000
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	503000
CY2021Q2	ofix	Cares Act2020 Impact On Income Tax Expense Benefit CARESAct2020ImpactOnIncomeTaxExpenseBenefit	0
	ofix	Cares Act2020 Impact On Income Tax Expense Benefit CARESAct2020ImpactOnIncomeTaxExpenseBenefit	0
CY2020Q2	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13900000
CY2020Q4	ofix	Cares Act Of2020 Deferred Taxes Payments CARESActOf2020DeferredTaxesPayments	600000
CY2021Q2	us-gaap	Deferred Long Term Liability Charges DeferredLongTermLiabilityCharges	0
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4155000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4840000
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	19641000
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	20552000
	us-gaap	Operating Lease Payments OperatingLeasePayments	2327000
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9625000
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8442000
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15742000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12149000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14654000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	29142000
CY2021Q2	ofix	Inventory Field And Consignment Net Of Reserves InventoryFieldAndConsignmentNetOfReserves	41530000
CY2020Q4	ofix	Inventory Field And Consignment Net Of Reserves InventoryFieldAndConsignmentNetOfReserves	34902000
CY2021Q2	us-gaap	Inventory Net InventoryNet	81551000
CY2020Q4	us-gaap	Inventory Net InventoryNet	84635000
CY2021Q2	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	23796000
CY2020Q4	ofix	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	25392000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2107000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2092000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2551000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	510000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2212000
	us-gaap	Operating Lease Payments OperatingLeasePayments	2082000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	452000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11000000.0
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2020Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13851000
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13851000
CY2021Q2	ofix	Recoupment Recognized In Net Sales RecoupmentRecognizedInNetSales	-2880000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	304000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	400000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	149000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2946000
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	20193000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	22338000
CY2021Q2	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	27063000
CY2020Q4	ofix	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	27886000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	260000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	124000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	415000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1949000
CY2021Q2	ofix	Future Contingent Milestone Payments FutureContingentMilestonePayments	30000.0
	ofix	Recoupment Recognized In Net Sales RecoupmentRecognizedInNetSales	-2880000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10971000
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10971000
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13851000
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6942000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15002000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13269000
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-550000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021Q2	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	12777000
CY2020Q2	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	-8989000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	14614000
CY2021Q2	ofix	Marketing Service Fees MarketingServiceFees	14447000
CY2020Q2	ofix	Marketing Service Fees MarketingServiceFees	10700000
	ofix	Marketing Service Fees MarketingServiceFees	27777000
	ofix	Marketing Service Fees MarketingServiceFees	24102000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	226987000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	177958000
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4506000
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5591000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4848000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3987000
	ofix	Impact Of Adoption Of Asu201613 ImpactOfAdoptionOfASU201613	1120000
CY2021Q2	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	-100000
CY2020Q2	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	-500000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	400000
	ofix	Estimated Sales And Marketing Expense Benefit EstimatedSalesAndMarketingExpenseBenefit	700000
CY2021Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	7300000
CY2021Q2	ofix	Freezing Amount In Cash Resulted From Court Pending Legal Action Issued FreezingAmountInCashResultedFromCourtPendingLegalActionIssued	600000
CY2021Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1700000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121394000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73135000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	226987000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	177958000
	ofix	Percentage Of Reported Increase Decrease PercentageOfReportedIncreaseDecrease	0.276
CY2021Q2	ofix	Revenue From Product Sales RevenueFromProductSales	106947000
CY2020Q2	ofix	Revenue From Product Sales RevenueFromProductSales	62435000
	ofix	Revenue From Product Sales RevenueFromProductSales	199210000
	ofix	Revenue From Product Sales RevenueFromProductSales	153856000
CY2021Q2	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	32000
CY2020Q2	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	-885000
	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	214000
	ofix	Current Period Provision Recovery For Expected Credit Losses CurrentPeriodProvisionRecoveryForExpectedCreditLosses	-1564000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	34000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	224000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	80000
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	338000
CY2021Q2	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-31000
CY2020Q2	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-112000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	83000
	ofix	Effect Of Changes In Foreign Exchange Rates EffectOfChangesInForeignExchangeRates	-31000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4471000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6364000
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4471000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6364000
CY2020Q2	ofix	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	13900000
CY2021Q4	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	11 months
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7559000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	-3904000
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-901000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-967000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1324000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4668000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16832000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1355000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11199000
	ofix	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	3394000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3907000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	121394000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73135000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	226987000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	177958000
CY2021Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1575000
CY2020Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2100000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-75000
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-6900000
CY2021Q2	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	1969000
CY2020Q2	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	1578000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	3938000
	ofix	Acquisition Related Amortization Expense AcquisitionRelatedAmortizationExpense	2996000
CY2021Q2	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	500000
	ofix	Business Combination Acquired In Process Research And Development BusinessCombinationAcquiredInProcessResearchAndDevelopment	1500000
CY2021Q2	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	894000
CY2020Q2	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	3678000
	ofix	Business Combination Acquisition Related Amortization And Remeasurement BusinessCombinationAcquisitionRelatedAmortizationAndRemeasurement	5363000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3907000
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4699000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7628000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8558000
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4699000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7628000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8558000
CY2021Q1	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	194745
CY2020Q1	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	152885
	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	245255
	ofix	Stock Shares Issued Net Of Shares For Tax Withholdings StockSharesIssuedNetOfSharesForTaxWithholdings	186444
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.482
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.095
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.506
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.647
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19650610
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19215392
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19575127
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19149523
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19938392
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19215392
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19575127
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19271467

Files In Submission

Name	View Source	Status
0001564590-21-041921-index-headers.html	Edgar Link	pending
0001564590-21-041921-index.html	Edgar Link	pending
0001564590-21-041921.txt	Edgar Link	pending
0001564590-21-041921-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gyont0jmiucj000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ofix-10q_20210630.htm	Edgar Link	pending
ofix-10q_20210630_htm.xml	Edgar Link	completed
ofix-20210630.xsd	Edgar Link	pending
ofix-20210630_cal.xml	Edgar Link	unprocessable
ofix-20210630_def.xml	Edgar Link	unprocessable
ofix-20210630_lab.xml	Edgar Link	unprocessable
ofix-20210630_pre.xml	Edgar Link	unprocessable
ofix-ex311_7.htm	Edgar Link	pending
ofix-ex312_8.htm	Edgar Link	pending
ofix-ex321_6.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OFIX
Orthofix Medical Inc. Stock $ofix

2021 Q2 Form 10-Q Financial Statement

#000156459021041921 Filed on August 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX Orthofix Medical Inc. Stock $ofix

2021 Q2 Form 10-Q Financial Statement

#000156459021041921 Filed on August 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OFIX
Orthofix Medical Inc. Stock $ofix